• B-cells from CdLS patients have altered IGH repertoires with a reduced diversity and skewed VH usage.
. We next analyzed the IGH repertoire in five NIPBL and three SMC1A mutated CdLS patients (Table E1 ). The overall diversity of the IGHV repertoire, estimated by either the proportion of sequences with a unique CDR3 divided by the total number of sequences, or by D50, which is a measurement of the evenness of the distribution of B cell clones, was significantly lower in the patients with NIPBL or SMC1A mutations (Fig. 1a, b) . Thus, the CdLS patients had a reduced overall diversity of their IGHV regions, with an overrepresentation of large B cell clones.
Furthermore, in NIPBL mutated patients with the classical form disease and in SMC1A mutated patients, the frequency of IGHV genes located in the most proximal one third of the IGH locus (about 250 kb) was increased (Fig. E2a, b, Fig. 1c ). The observed skewed pattern of VH genes in the patients is likely to be a result of B-cell intrinsic changes, as only sequences resulting from unproductive rearrangement (successfully rearranged, but out of reading-frame or containing stop codons) were included in this analysis and an influence of antigen selection can thus be excluded.
The overall mutation frequency in the unproductive, most commonly mutated IGHV genes was also reduced in the CdLS patients, reaching a statistical significance for the NIPBL mutated group (Fig. 2a) . The proportion of un-mutated sequences was increased in the NIPBL mutated patients, especially in those with the classical form of disease (Fig. 2a) . The pattern of base pair substitution in the V regions was, however, largely normal in the patients (Fig. 2b) . (5, 6) , (7) .
Another possible explanation of how NIPBL/SMC1A could affect V(D)J recombination could be a change in regulation of DNA repair. We have previously observed a correlation between heterozygous NIPBL loss-of-function mutations and increased sensitivity to γ-radiation and a shift towards the use of a microhomologybased end joining during CSR, suggesting that NIPBL regulates the NHEJ process(4).
However, the V(D)J coding junctions generated in vivo in CdLS patients showed a normal repair pattern (Table E2) . Furthermore, the expression of a number of key V(D)J recombination factors was largely normal in NIPBL knockdown cells (Fig.   E3b ). Thus, the core NHEJ machinery appears to be retained in CdLS patients.
We also found a reduced frequency of mutations within the IGHV regions in CdLS patients. NIPBL and SMC1A could both be involved in the SHM process through regulation of transcription or RNA polymerase pausing, which promotes the formation of single-stranded DNA and AID targeting. In support of this notion, there was a reduced number of mutations observed in the RGYW motifs (containing the M A N U S C R I P T A C C E P T E D (Table E3) Eight CdLS patients were included in the study (Table E1) . Five had heterozygous mutations 3 in the NIPBL gene, of which two (P3, P6) had a more severe, classical form of CdLS, 4 whereas three (P8, P10, P11) had a milder form of disease. In addition, three male patients 5 had mutations within the SMC1A gene, located on the X chromosome (SMC1A-1, SMC1A-2 6 and SMC1A-4). The clinical features of seven of the eight patients have been described 7 previously [1] [2] [3] . Seven unaffected controls were also included in the study (Table E1 ). DNA was 8 isolated from peripheral blood using standard methods. The study was approved by the 9 institutional review board at the Karolinska Institutet. efficiency by measurement of expression of GFP or CD4 respectively. The gene knockdown 27 efficiency was monitored by real-time PCR (Fig. E1b) as described previously 4 . 28
29
A murine B-abl pro-B-cell line (with a Bcl2 transgene) carrying the chromosome integrated 30 MX-RSS-INV substrate was previously described 7 . The cells were treated with either Nipbl or 31 control smart pool mouse siRNA (GE Dharmacon, Lafayette, CO, USA) using a nucleofector 32 kit (Lonza, Basel, Switzerland) for 48 hours and then treated with 0.3 µM abl kinase inhibitorM A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
(PD-180970, Sigma-Aldrich, St. Louis, MO, USA), which leads to G1 cell cycle arrest and an 34 induction/stabilization of expression of RAG1/RAG2 8 . Recombination activity were 35 subsequently assessed as percentages of GFP + cells by flow-cytometry. The gene knockdown 36 efficiency was monitored by real-time PCR (Fig. E1c) . 37 38
Amplification and high throughput sequencing of IGHV regions from CdLS patients 39
Ig genes were amplified using a semi-nested PCR as previously described 9 with the exception 40 IGHV gene, at either end, the sequence was omitted from IGHV gene usage analysis. For 54 SHM analysis, chimeric sequences were also omitted, except if the sequence was chimeric at 55 the first half of the IGHV region sequence, then the remaining part was still included in the 56 analysis. Only unique, unproductive sequences (VH and JH genes are not in the same reading 57 frame or containing premature stop codons) were included for the VH gene usage and SHM 58 analyses, in order to avoid any antigen selection bias from the expressed repertoire. The error 59 rate of 454 sequencing was previously determined to be less than 1 error per 1300 bp when 60 indels were excluded 9 . 61 62
Real-time PCR 63
One µg of total RNA was used to synthesize cDNA according to the manufacturer's protocol 64 This report a. Productive: as a result of V(D)J recombination, the VH, DH and JH genes are in the correct translational reading-frame. b. Diversity was calculated by dividing sequences with unique CDR3s with the total sequences. Sequences not spanning the CDR3 region were omitted from calculation. c. Only unproductive rearrangement (out of reading-frame or contain a stop codon), unique sequences, not chimeric at both ends, were included in V gene analysis. d. This mutation has been shown to yield two transcripts, of which one bears an exon 20 deletion and the other is of ordinary size but with a V1441L change 
